Bicycle Therapeutics Plc ADR
(BCYC)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2019 | 12-2018 | 12-2017 | 12-2006 | |
| Cash Flows From Operating Activities | ||||
| Net Income | -30,608 | -21,846 | -16,259 | N/A |
| Depreciation Amortization | 960 | 712 | 332 | N/A |
| Accounts receivable | 4,909 | -400 | N/A | N/A |
| Accounts payable and accrued liabilities | 220 | -169 | 67 | N/A |
| Other Working Capital | -8,141 | -6,632 | 13,022 | N/A |
| Other Operating Activity | 4,047 | 2,257 | 1,423 | 0 |
| Operating Cash Flow | $-28,613 | $-26,078 | $-1,415 | $N/A |
| Cash Flows From Investing Activities | ||||
| PPE Investments | -1,555 | -1,186 | -1,113 | N/A |
| Investing Cash Flow | $-1,555 | $-1,186 | $-1,113 | $N/A |
| Cash Flows From Financing Activities | ||||
| Common Stock Issued | 57,106 | 1 | N/A | N/A |
| Common Stock Repurchased | N/A | N/A | 1 | N/A |
| Other Financing Activity | 1,334 | 25,429 | 57,875 | 0 |
| Financing Cash Flow | $58,440 | $25,430 | $57,876 | $N/A |
| Exchange Rate Effect | 465 | -2,449 | 2,913 | N/A |
| Beginning Cash Position | 63,380 | 67,663 | 9,402 | N/A |
| End Cash Position | 92,117 | 63,380 | 67,663 | N/A |
| Net Cash Flow | $28,737 | $-4,283 | $58,261 | $N/A |
| Free Cash Flow | ||||
| Operating Cash Flow | -28,613 | -26,078 | -1,415 | N/A |
| Capital Expenditure | -1,555 | -1,186 | -1,113 | N/A |
| Free Cash Flow | -30,168 | -27,264 | -2,528 | 0 |